BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33491826)

  • 1. Marked loss of adipose tissue during neoadjuvant therapy as a predictor for poor prognosis in patients with gastric cancer: A retrospective cohort study.
    Zhang Y; Li Z; Jiang L; Xue Z; Ma Z; Kang W; Ye X; Liu Y; Jin Z; Yu J
    J Hum Nutr Diet; 2021 Jun; 34(3):585-594. PubMed ID: 33491826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of body composition on clinical outcomes in people with gastric cancer undergoing radical gastrectomy after neoadjuvant treatment.
    Zhang Y; Li Z; Jiang L; Xue Z; Ma Z; Kang W; Ye X; Liu Y; Jin Z; Yu J
    Nutrition; 2021 May; 85():111135. PubMed ID: 33556785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral Adipose Tissue Assessment Enhances the Prognostic Value of GLIM Criteria in Patients with Gastric Cancer Undergoing Radical Gastrectomy after Neoadjuvant Treatment.
    Zhang Y; Jiang L; Su P; Yu T; Ma Z; Kang W; Liu Y; Jin Z; Yu J
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial.
    Park HS; Kim HS; Beom SH; Rha SY; Chung HC; Kim JH; Chun YJ; Lee SW; Choe EA; Heo SJ; Noh SH; Hyung WJ; Cheong JH; Kim HI; Son T; Lim JS; Baek SE; Jung M
    Ann Surg Oncol; 2018 Oct; 25(11):3222-3230. PubMed ID: 30051367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral-to-subcutaneous fat ratio independently predicts the prognosis of locally advanced gastric cancer----- highlighting the role of adiponectin receptors and PPARα, β/ δ, ɤ.
    Lin YC; Lin G; Yeh TS
    Eur J Surg Oncol; 2021 Dec; 47(12):3064-3073. PubMed ID: 33941417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body composition parameters predict pathological response and outcomes in locally advanced gastric cancer after neoadjuvant treatment: A multicenter, international study.
    Lin JX; Tang YH; Zhou WX; Desiderio J; Parisi A; Xie JW; Wang JB; Cianchi F; Antonuzzo L; Borghi F; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Staderini F; Marano A; Peluso C; Li P; Zheng CH; Ma YB; Huang CM
    Clin Nutr; 2021 Aug; 40(8):4980-4987. PubMed ID: 34364237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of visceral adipose tissue precedes subcutaneous adipose tissue and associates with n-6 fatty acid content.
    Ebadi M; Baracos VE; Bathe OF; Robinson LE; Mazurak VC
    Clin Nutr; 2016 Dec; 35(6):1347-1353. PubMed ID: 26972089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight Loss and Changes in Adipose Tissue and Skeletal Muscle Volume after Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: a Prospective Study with 12-Month Follow-Up.
    Kenngott HG; Nickel F; Wise PA; Wagner F; Billeter AT; Nattenmüller J; Nabers D; Maier-Hein K; Kauczor HU; Fischer L; Müller-Stich BP
    Obes Surg; 2019 Dec; 29(12):4018-4028. PubMed ID: 31309523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer.
    Sandini M; Patino M; Ferrone CR; Alvarez-Pérez CA; Honselmann KC; Paiella S; Catania M; Riva L; Tedesco G; Casolino R; Auriemma A; Salandini MC; Carrara G; Cristel G; Damascelli A; Ippolito D; D'Onofrio M; Lillemoe KD; Bassi C; Braga M; Gianotti L; Sahani D; Fernández-Del Castillo C
    JAMA Surg; 2018 Sep; 153(9):809-815. PubMed ID: 29801062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral and subcutaneous fat as new independent predictive factors of survival in locally advanced gastric carcinoma patients treated with neo-adjuvant chemotherapy.
    Li XT; Tang L; Chen Y; Li YL; Zhang XP; Sun YS
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1237-47. PubMed ID: 25537963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous, but not visceral, adipose tissue as a marker for prognosis in gastric cancer patients with cachexia.
    Han J; Tang M; Lu C; Shen L; She J; Wu G
    Clin Nutr; 2021 Sep; 40(9):5156-5161. PubMed ID: 34461589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer.
    Nakano O; Kawai H; Kobayashi T; Kohisa J; Ikarashi S; Hayashi K; Yokoyama J; Terai S
    Cancer Med; 2021 Jul; 10(13):4291-4301. PubMed ID: 33993635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of visceral adipose tissue on compliance of adjuvant chemotherapy and relapse-free survival after gastrectomy for gastric cancer: A propensity score matching analysis.
    Matsui R; Inaki N; Tsuji T
    Clin Nutr; 2021 May; 40(5):2745-2753. PubMed ID: 33933740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of radiological features of adipose tissues with postoperative complications and overall survival of gastric cancer patients.
    Bian L; Wu D; Chen Y; Ni J; Qu H; Li Z; Chen X
    Eur Radiol; 2022 Dec; 32(12):8569-8578. PubMed ID: 35704109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
    Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
    Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative BMI Loss at One Year Correlated with Poor Outcomes in Chinese Gastric Cancer Patients.
    Wang N; Jiang J; Xi W; Wu J; Zhou C; Shi M; Wang C; Zhu Z; Liu J; Zhang J
    Int J Med Sci; 2020; 17(15):2276-2284. PubMed ID: 32922192
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of visceral adipose tissue on long-term outcomes after gastrectomy for advanced gastric cancer.
    Matsui R; Inaki N; Tsuji T
    Nutrition; 2022 May; 97():111619. PubMed ID: 35231854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer.
    Yip C; Goh V; Davies A; Gossage J; Mitchell-Hay R; Hynes O; Maisey N; Ross P; Gaya A; Landau DB; Cook GJ; Griffin N; Mason R
    Eur Radiol; 2014 May; 24(5):998-1005. PubMed ID: 24535076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of CT attenuation and F-18 fluorodeoxyglucose uptake of visceral adipose tissue for predicting survival in gastric cancer patients after curative surgical resection.
    Lee JW; Son MW; Chung IK; Cho YS; Lee MS; Lee SM
    Gastric Cancer; 2020 Mar; 23(2):273-284. PubMed ID: 31485803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.